Novo Nordisk and Vivtex Corporation have entered into a partnership to develop next-generation oral biologic medicines for ...

Novo Nordisk is deeply undervalued, trading at distressed multiples despite a robust pipeline and strong financials. Learn ...

Eli Lilly released new data on its oral pill, orforglipron, Thursday, showing it's almost as good as Ozempic. The pill may be ...

For some reason, YouTube is convinced that my husband is a fat Latino. Apparently, watching hours-long videos of classical music, the occasional pickleball championship, and indulging in a daily dose ...

GoodRx Holdings, Inc. ( GDRX) Q4 2025 Earnings Call February 26, 2026 8:00 AM EST Ladies and gentlemen, thank you for standing by, and welcome to the GoodRx Fourth Quarter and Full Year 2025 Earnings ...

Victory Capital has put in a bid to buy UK asset manager Janus Henderson, in a move aimed at gatecrashing an earlier deal agreed with Nelson Peltz’s Trian Fund Management and General Catalyst.

Q4 2025 Management View Wendy Barnes, President and CEO, emphasized that "the fourth quarter marked a strong finish to the year and reflected disciplined execution across our strategic priorities." ...

The newly-approved device requires only that patients swallow it in their doctor's office to achieve weight loss, according to Allurion Technologies.

Watch Health Matters: 1 in 4 Canadians living in LTC homes were prescribed anti-psychotic medication without diagnosis, CIHI report says Video Online, on GlobalNews.ca ...